(WHTM) — Pennsylvania could receive $28 million in its latest opioid settlement.

Attorney General Dave Sunday announced Thursday that the state is part of an approximately $720 million combined national settlement with eight drug manufacturers that worsened the nationwide opioid crisis.

“These funds come out of the pockets of companies that contributed to the nationwide addiction epidemic and into Pennsylvania communities,” Sunday said.

The state could receive as much as $28 million from the settlement, depending on how many local governments participate during the sign-on period, Sunday said.

The eight companies and their payment shares are:

• Mylan (now part of Viatris): $284,447,916 paid over nine years
• Hikma: $95,818,293 paid over one to four years
• Amneal: $71,751,010 paid over 10 years
• Apotex: $63,682,369 paid in a single year
• Indivior: $38,022,450 paid over four years
• Sun: $30,992,087 paid over one to four years
• Alvogen: $18,680,162 paid in a single year
• Zydus: $14,859,220 paid in a single year

All companies, except for Indivior, are prohibited from promoting or marketing opioids and opioid products, and making or selling any product that contains more than 40 mg of oxycodone per pill.

Additionally, the seven companies must put in place a monitoring and reporting system for suspicious orders.

Indivior has agreed to not manufacture or sell opioid products for the next 10 years, but it will be able to continue marketing and selling medications used to treat opioid use disorder.

The settlement comes on the heels of a $7.4 billion settlement with Purdue Pharma and its owners for contributing to the nationwide opioid epidemic.

Pennsylvania will receive an estimated $200 million from that settlement, depending on how many municipalities sign on, Sunday said.

Last year, the U.S. Supreme Court rejected a version of Purdue’s proposed settlement after it generated controversy over a clause protecting members of the Sackler family from lawsuits over opioids.

In the final version, groups that don’t opt in to the settlement would still have the right to sue members of the wealthy family.

The Sacklers also gave up ownership of Purdue as part of the settlement.